Philip Morris International Inc. (PMI) - 10-Q Summary for Period Ended June 30, 2025
Business Context and Reporting Period
This report covers the quarterly period ended June 30, 2025. PMI is a leading international consumer goods company focused on transitioning from combustible cigarettes to smoke-free products (SFPs), including heat-not-burn, e-vapor, and oral nicotine products. The company operates in four geographic segments: Europe, South and Southeast Asia, Commonwealth of Independent States, Middle East and Africa (SSEA, CIS & MEA), East Asia, Australia & PMI Global Travel Retail (EA, AU & PMI GTR), and the Americas. In January 2025, PMI updated its segment reporting to include Wellness & Healthcare results within the Europe segment following the sale of Vectura Group Ltd.
Key Financial Metrics (Six Months Ended June 30, 2025)
| Metric | 2025 (YTD) | 2024 (YTD) | Change |
|---|---|---|---|
| Net Revenues | $19,441 million | $18,261 million | +6.5% |
| Operating Income | $7,256 million | $6,489 million | +11.8% |
| Net Earnings Attributable to PMI | $5,729 million | $4,554 million | +25.8% |
| Diluted EPS | $3.67 | $2.92 | +25.7% |
| Operating Cash Flow | $3,062 million | $4,873 million | -37.2% |
| Total Debt | $51.5 billion | $45.7 billion (Dec 31, 2024) | N/A |
| Cash and Cash Equivalents | $4,138 million | $4,216 million (Dec 31, 2024) | -1.9% |
Segment Performance (YTD 2025 Operating Income): Europe ($3,105M), SSEA, CIS & MEA ($1,920M), EA, AU & PMI GTR ($1,766M), and Americas ($465M).
Material Changes vs. Prior Period
- Revenue Growth: Net revenues increased 6.5% year-over-year, driven by an 8.4% increase excluding currency and acquisitions/divestitures. This was primarily due to favorable pricing (combustible tobacco) and favorable volume/mix (smoke-free products), offset by lower cigarette volumes.
- Profitability: Operating income grew 11.8%, despite a $41 million goodwill impairment charge in the Europe segment and $243 million in restructuring charges related to the closure of two German factories.
- Smoke-Free Growth: Smoke-free revenues increased 15.1% to $8.05 billion. Oral SFP shipment volume grew 28.8% year-over-year, driven by ZYN nicotine pouches in the U.S.
- Cash Flow Decline: Operating cash flow decreased significantly to $3.1 billion from $4.9 billion in the prior year. This was primarily due to higher working capital requirements ($3.0 billion), including increased inventory and accrued liabilities, and a $0.8 billion payment of a disputed supplemental tax surcharge on heated tobacco products in Germany.
- Debt Issuance: PMI issued $3.6 billion in new debt during the first six months of 2025 to refinance maturing notes and fund general corporate purposes.
Guidance, Outlook, and Risks
- 2025 Outlook: PMI expects total cigarette and smoke-free product shipment volume growth of around 1% for the full year. Smoke-free product volume growth is forecast at 12% to 14%, partly offset by cigarette volume declines of around 2%. The company expects net cash provided by operating activities to be approximately $11.5 billion for the full year.
- Restructuring: The company recorded $243 million in pre-tax restructuring charges in Q2 2025 related to ending combustible tobacco production in Berlin and Dresden, Germany. Future cash payments are anticipated to be substantially paid by the end of 2026.
- Goodwill Impairment: A $41 million impairment charge was recorded in the Europe segment following an annual review, representing the entirety of goodwill in one reporting unit.
- Legal and Regulatory Risks:
- Canada Litigation: A CCAA plan was approved in March 2025 resolving combustible tobacco litigation in Canada, involving an aggregate settlement of CAD 32.5 billion. PMI's investment in Rothmans, Benson & Hedges Inc. (RBH) was previously impaired by $2.3 billion in Q4 2024.
- U.S. Litigation: Multiple class actions and individual complaints regarding ZYN nicotine pouches are pending in U.S. courts, alleging addiction and marketing to minors. No estimated loss has been accrued.
- Tax Disputes: Ongoing disputes regarding the classification of heated tobacco products in Germany and Japan, as well as indirect tax assessments in Brazil.
- Geopolitical: Continued risks related to operations in Russia and Ukraine, including potential asset impairment and currency volatility.
Key Facts for Investor Verification
- Smoke-Free Transition: Verify the sustainability of the 15.1% revenue growth in smoke-free products and the 28.8% volume growth in oral SFPs, particularly the ZYN brand in the U.S.
- Working Capital Impact: Assess the drivers behind the $1.9 billion unfavorable variance in operating cash flow, specifically the timing of excise tax payments and inventory movements.
- German Restructuring: Monitor the execution of the factory closures in Germany and the associated cash outflows for employee separation and contract termination costs.
- Legal Exposure: Track the status of the Canadian CCAA plan implementation and the outcomes of pending U.S. litigation regarding ZYN nicotine pouches.
- Debt Profile: Review the impact of new debt issuances on the weighted average cost of debt and future interest expense, noting the prepayment of the 3-year tranche of the Swedish Match term loan.